Should infectious disease modelling research be subject to ethics review?

Bioethics Epidemiology Modelling Peer review Principlism Research ethics Research integrity

Journal

Philosophy, ethics, and humanities in medicine : PEHM
ISSN: 1747-5341
Titre abrégé: Philos Ethics Humanit Med
Pays: England
ID NLM: 101258058

Informations de publication

Date de publication:
04 08 2023
Historique:
received: 10 01 2023
accepted: 17 06 2023
medline: 7 8 2023
pubmed: 4 8 2023
entrez: 3 8 2023
Statut: epublish

Résumé

Should research projects involving epidemiological modelling be subject to ethical scrutiny and peer review prior to publication? Mathematical modelling had considerable impacts during the COVID-19 pandemic, leading to social distancing and lockdowns. Imperial College conducted research leading to the website publication of a paper, Report 9, on non-pharmaceutical interventions (NPIs) and COVID-19 mortality demand dated 16th March 2020, arguing for a Government policy of non-pharmaceutical interventions (e.g. lockdowns, social distancing, mask wearing, working from home, furlough, school closures, reduced family interaction etc.) to counter COVID 19. Enquiries and Freedom of Information requests to the institution indicate that there was no formal ethical committee review of this specific research, nor was there any peer review prior to their online publication of Report 9. This paper considers the duties placed upon researchers, institutions and research funders under the UK 'Concordat to Support Research Integrity' (CSRI), across various bioethical domains, and whether ethical committee scrutiny should be required for this research.

Identifiants

pubmed: 37537645
doi: 10.1186/s13010-023-00138-4
pii: 10.1186/s13010-023-00138-4
pmc: PMC10401793
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

11

Informations de copyright

© 2023. The Author(s).

Références

CMAJ. 2021 May 31;193(22):E811-E812
pubmed: 34059501
Br J Psychiatry. 2021 Jun;218(6):334-343
pubmed: 33228822
BMC Res Notes. 2017 Dec 29;10(1):777
pubmed: 29284529
Prev Vet Med. 2013 Nov 1;112(3-4):161-73
pubmed: 23958457
Nature. 2002 Jan 24;415(6870):420-4
pubmed: 11786878
Lancet Infect Dis. 2009 Aug;9(8):473-81
pubmed: 19628172
Nature. 2005 Sep 8;437(7056):209-14
pubmed: 16079797
Bull Math Biol. 2020 Apr 8;82(4):52
pubmed: 32270376
J Econ Dyn Control. 2023 Jan;146:104581
pubmed: 36506795
Science. 2001 May 11;292(5519):1155-60
pubmed: 11303090
BMJ. 2020 Nov 2;371:m4074
pubmed: 33139247

Auteurs

Ben Green (B)

The Medical School, University of Central Lancashire, Preston, Lancashire, UK. BGreen5@uclan.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH